Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :958
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Quinalizarin, a specific CK2 inhibitor, reduces cell viability and suppresses migration and accelerates apoptosis in different human lung cancer cell lines

Zhou Y, Li K, Zhang S, Li Q, Li Z, Zhou F, Dong X, Liu L, Wu G, Meng R

Year : 2015| Volume: 52| Issue : 6 | Page no: 119-124

   This article has been cited by
 
1 Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT-4 and HCT 116 Cells
Sayantani Mukherjee Chatterjee,Chetan Kumar Jain,Soumen Singha,Piyal Das,Susanta Roychoudhury,Hemanta Kumar Majumder,Saurabh Das
ACS Omega. 2018; 3(8): 10255
[Pubmed]  [Google Scholar] [DOI]
2 CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
Melissa Chua,Charina Ortega,Ayesha Sheikh,Migi Lee,Hussein Abdul-Rassoul,Kevan Hartshorn,Isabel Dominguez
Pharmaceuticals. 2017; 10(4): 18
[Pubmed]  [Google Scholar] [DOI]
3 Association of protein kinase CK2 inhibition with cellular radiosensitivity of non-small cell lung cancer
Qianwen Li,Ke Li,Tianyang Yang,Sheng Zhang,Yu Zhou,Zhenyu Li,Jinrong Xiong,Fangzheng Zhou,Xiaoshu Zhou,Li Liu,Rui Meng,Gang Wu
Scientific Reports. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow